Argeris N. Karabelas, Chairman of the Board at Vanda Pharmaceuticals Inc. (VNDA), sold 326,325 shares at $26.40 ($8.6M) on 2006-12-11, disclosed to the SEC on 2006-12-13.
Open-market sale of $8.6M VNDA by Chairman of the Board. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.40 | 20,950 | $553K | 6.4% |
| 2 | $26.40 | 305,375 | $8.1M | 93.6% |
| Total | $26.40 avg | 326,325 | $8.6M | 100% |
| Filing → |
| RGNX | SELL | 2024-08-05 | $136K | — | Filing → |
| RGNX | SELL | 2024-07-30 | $166K | — | Filing → |
| RGNX | SELL | 2024-07-03 | $113K | — | Filing → |